Teladoc Health, Inc. (TDOC)

Teladoc Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-207.36	-1,001	-220.37	-13,660	-428.79	-485.14
Depreciation & Amortization	210.96	249.81	265.76	221.69	219.62	70.59
Other Amortization	157.59	133.04	82.96	46.1	-	7.5
Asset Writedown & Restructuring Costs	59.14	790	-	13,403	-	-
Loss (Gain) From Sale of Investments	-	-	-	-	-5.9	-
Stock-Based Compensation	109.03	145.95	201.55	217.85	302.59	475.53
Provision & Write-off of Bad Debts	3.36	3.8	4.69	2.82	10.6	5.28
Other Operating Activities	-27.44	8.65	3.79	5.95	139.86	-36.79
Change in Accounts Receivable	-5.9	-0.38	-10.25	-49.06	-11.17	-21.09
Change in Inventory	-2.86	-9.75	24.1	14.8	-19.49	-24.73
Change in Accounts Payable	-3.7	-10.37	-4.18	1.88	1.19	-88
Change in Unearned Revenue	-22.69	-18.25	-4.9	15.24	20.55	17.75
Change in Other Net Operating Assets	33.3	2.42	6.89	-31.25	-35.06	25.58
Operating Cash Flow	303.43	293.68	350.02	189.29	193.99	-53.51
Operating Cash Flow Growth	-8.96%	-16.10%	84.91%	-2.42%	-	-
Capital Expenditures	-11.72	-10.79	-11.46	-16.48	-8.53	-4.02
Cash Acquisitions	-65.3	-	-	-	-78.66	-567.43
Sale (Purchase) of Intangibles	-140.46	-113.26	-144.88	-156.28	-55.4	-22.02
Investment in Securities	-26.34	-	-	2.51	60.9	2.5
Other Investing Activities	0.06	-	0	2.51	8.72	-
Investing Cash Flow	-243.76	-124.05	-156.35	-167.74	-72.98	-590.98
Long-Term Debt Issued	-	-	-	-	-	1,098
Long-Term Debt Repaid	-	-	-	-	-	-246.79
Net Debt Issued (Repaid)	-550.63	-	-	-	-	850.87
Issuance of Common Stock	4.3	8.31	11.13	12.39	42.59	59.04
Repurchase of Common Stock	-	-	-	-	-	-26.7
Other Financing Activities	-0.08	-0	-0.28	-5.89	-1.64	-24.07
Financing Cash Flow	-546.41	8.31	10.85	6.5	40.95	859.14
Foreign Exchange Rate Adjustments	3.97	-3.29	0.97	-3.34	-1.8	4.32
Net Cash Flow	-482.76	174.65	205.49	24.7	160.16	218.97
Free Cash Flow	291.71	282.89	338.56	172.81	185.46	-57.54
Free Cash Flow Growth	-9.70%	-16.44%	95.91%	-6.82%	-	-
Free Cash Flow Margin	11.47%	11.01%	13.01%	7.18%	9.12%	-5.26%
Free Cash Flow Per Share	1.68	1.66	2.06	1.07	1.18	-0.64
Cash Interest Paid	17.32	17.32	17.42	17.36	18.84	14.89
Cash Income Tax Paid	9.99	8.95	7.24	2.51	3.97	1.32
Levered Free Cash Flow	209.72	229.78	303.95	176.62	241.62	206.75
Unlevered Free Cash Flow	223.93	244.65	317.88	190.34	292.34	244.22

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q